INTERNATIONAL PATENT: SEAGEN INC. FILES APPLICATION FOR "MULTISPECIFIC EGFR ANTIBODIES AND USE IN THE TREATMENT OF CANCER"

GENEVA, June 25 -- SEAGEN INC. (21823 30th Drive SEBothell, Washington 98021) filed a patent application (PCT/US2024/059445) for "MULTISPECIFIC EGFR ANTIBODIES AND USE IN THE TREATMENT OF CANCER" on Dec 11, 2024. With publication no. WO/2025/128615, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PALANCA-WESSELS, Corinna (c/o Seagen Inc. 21823 30th Drive SEBothell, Washington 98021), LI, Hong (c/o Seagen Inc. 21823 30th Drive SEBothell, Washington 98021), GUPTA, Priyanka (c/o Seagen Inc. 21823 30th Drive SEBothell, Washin...